77
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Improvement of liraglutide release from PLGA microspheres by a porous microsphere-gel composite system

, &
Pages 291-299 | Received 05 Oct 2023, Accepted 08 Mar 2024, Published online: 18 Mar 2024

References

  • Baruch L, Machluf M. 2006. Alginate–chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on long-term viability. Biopolymers. 82(6):570–579. doi: 10.1002/bip.20509.
  • Bee SL, Hamid ZAA, Mariatti M, Yahaya BH, Lim K, Bee S-T, Sin LT. 2018. Approaches to Improve therapeutic efficacy of biodegradable PLA/PLGA microspheres: a review. Polym Rev. 58(3):495–536. doi: 10.1080/15583724.2018.1437547.
  • Cole JB, Florez JC. 2020. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 16(7):377–390. doi: 10.1038/s41581-020-0278-5.
  • Dang Y, Guan J. 2020. Nanoparticle-based drug delivery systems for cancer therapy. Smart Mater Med. 1:10–19. doi: 10.1016/j.smaim.2020.04.001.
  • Donnelly D. 2012. The structure and function of the glucagon-like peptide-1 receptor and its ligands. Br J Pharmacol. 166(1):27–41. doi: 10.1111/j.1476-5381.2011.01687.x.
  • El-Maghawry E, Tadros MI, Elkheshen SA, Abd-Elbary A. 2020. Eudragit®-S100 coated PLGA Nanoparticles for colon targeting of etoricoxib: optimization and pharmacokinetic assessments in healthy human volunteers. Int J Nanomedicine. 15:3965–3980. doi: 10.2147/IJN.S244124.
  • Fredenberg S, Wahlgren M, Reslow M, Axelsson A. 2011. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems–a review[J]. Int J Pharm. 415(1–2):34–52.
  • Gasmi H, Siepmann F, Hamoudi MC, Danede F, Verin J, Willart JF, Siepmann J. 2016. Towards a better understanding of the different release phases from PLGA microparticles: dexamethasone-loaded systems. Int J Pharm. 514(1):189–199.
  • Gentilella R, Pechtner V, Corcos A, Consoli A. 2019. Glucagon‐like peptide‐1 receptor agonists in type 2 diabetes treatment: are they all the same?. Diabetes Metab Res Rev. 35(1):e3070. doi: 10.1002/dmrr.3070.
  • Ghosh Dastidar D, Saha S, Chowdhury M. 2018. Porous microspheres: synthesis, characterisation and applications in pharmaceutical & medical Fields. Int J Pharm. 548(1):34–48. doi: 10.1016/j.ijpharm.2018.06.015.
  • Gupta V, Khan Y, Berkland CJ, Laurencin CT, Detamore MS. 2017. Microsphere-based scaffolds in regenerative engineering. Annu Rev Biomed Eng. 19(1):135–161. doi: 10.1146/annurev-bioeng-071516-044712.
  • Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A. 2009. The effect of formulation variables on the characteristics of Insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation Method[J]. Colloids Surf B Biointerfaces. 74(1):340–349. doi: 10.1016/j.colsurfb.2009.08.003.
  • Hu X, Zhang J, Tang X, Li M, Ma S, Liu C, Gao Y, Zhang Y, Liu Y, Yu F, et al. 2018. An accelerated release method of risperidone loaded PLGA microspheres with good IVIVC. Curr Drug Deliv. 15(1):87–96. doi: 10.2174/1567201814666170516113406.
  • Hu Z, Liu Y, Yuan W, Wu F, Su J, Jin T. 2011. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids Surf B Biointerfaces. 86(1):206–211. doi: 10.1016/j.colsurfb.2011.03.043.
  • Jayakumar R, Nwe N, Tokura S, Tamura H. 2007. Sulfated chitin and chitosan as novel biomaterials. Int J Biol Macromol. 40(3):175–181. doi: 10.1016/j.ijbiomac.2006.06.021.
  • Jeong B, Windisch CF, Park MJ, Sohn YS, Gutowska A, Char K. 2003. Phase transition of the PLGA-g-PEG copolymer aqueous solutions. J. Phys. Chem. B. 107(37):10032–10039. doi: 10.1021/jp027339n.
  • Jiang Y, Hou Y, Fang J, Liu W, Zhao Y, Huang T, Cui J, Yang Y, Zhou Z. 2019. Preparation and characterization of PVA/SA/HA composite hydrogels for wound dressing. Int J Polym Anal Charact. 24(2):132–141. doi: 10.1080/1023666X.2018.1558567.
  • Kim MR, Lee S, Park J-K, Cho KY. 2010. Golf ball-shaped PLGA microparticles with internal pores fabricated by simple O/W emulsion. Chem Commun (Camb). 46(39):7433–7435. doi: 10.1039/c0cc01738h.
  • Klose D, Siepmann F, Elkharraz K, Krenzlin S, Siepmann J. 2006. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int J Pharm. 314(2):198–206. doi: 10.1016/j.ijpharm.2005.07.031.
  • Knudsen LB, Lau J. 2019. The discovery and development of liraglutide and semaglutide. Front Endocrinol (Lausanne). 10:155. doi: 10.3389/fendo.2019.00155.
  • Liu B, Dong Q, Wang M, Shi L, Wu Y, Yu X, Shi Y, Shan Y, Jiang C, Zhang X, et al. 2010. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres. Chem Pharm Bull (Tokyo). 58(11):1474–1479. doi: 10.1248/cpb.58.1474.
  • Mahmoudifar N, Doran PM. 2010. Chondrogenic differentiation of human adipose-derived stem cells in polyglycolic acid mesh scaffolds under dynamic culture conditions. Biomaterials. 31(14):3858–3867. doi: 10.1016/j.biomaterials.2010.01.090.
  • Ohlmann C-H, Gross-Langenhoff M. 2018. Efficacy and tolerability of leuprorelin acetate (Eligard®) in daily practice in Germany: pooled data from 2 prospective, non-interventional studies with 3- or 6-month depot formulations in patients with advanced prostate cancer. Urol Int. 100(1):66–71. doi: 10.1159/000479187.
  • Qi F, Wu J, Yang T, Ma G, Su Z. 2014. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification. Acta Biomater. 10(10):4247–4256. doi: 10.1016/j.actbio.2014.06.018.
  • Ren T, Chen J, Qi P, Xiao P, Wang P. 2022. Goserelin/PLGA solid dispersion used to prepare long-acting microspheres with reduced initial release and reduced fluctuation of drug serum concentration in vivo[J]. Int J Pharm. 615:121474. doi: 10.1016/j.ijpharm.2022.121474.
  • Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. 2017. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag. 20(1):6–12. doi: 10.1089/pop.2015.0181.
  • Ruan S, Gu Y, Liu B, Gao H, Hu X, Hao H, Jin L, Cai T. 2018. Long-acting release microspheres containing novel GLP-1 analog as an antidiabetic system. Mol Pharm. 15(7):2857–2869. doi: 10.1021/acs.molpharmaceut.8b00344.
  • Sabanayagam C, Chee ML, Banu R, Cheng CY, Lim SC, Tai ES, Coffman T, Wong TY. 2019. Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic Asian population. JAMA Netw Open. 2(3):e191540. doi: 10.1001/jamanetworkopen.2019.1540.
  • Sandholm N, Groop PH. 2018. Genetic basis of diabetic kidney disease and other diabetic complications. Curr Opin Genet Dev. 50:17–24. doi: 10.1016/j.gde.2018.01.002.
  • Shi Y, Zhang X, Mu K, Wang Y, Jiang T, Jiang S, Zhang S, Du Y. 2022. Precise fabrication of porous microspheres by iso-density emulsion combined with microfluidics. Polymers (Basel). 14(13):2687. doi: 10.3390/polym14132687.
  • Shojima N, Yamauchi T. 2023. Progress in genetics of type 2 diabetes and diabetic complications. J Diabetes Investig. 14(4):503–515. jdi.13970. doi: 10.1111/jdi.13970.
  • Smits MM, Van Raalte DH. 2021. Safety of semaglutide. Front Endocrinol (Lausanne). 12:786732. doi: 10.3389/fendo.2021.786732.
  • Wang T, Xue P, Wang A, Yin M, Han J, Tang S, Liang R. 2019. Pore change during degradation of octreotide Acetate-loaded PLGA microspheres: the effect of polymer blends. Eur J Pharm Sci. 138:104990. doi: 10.1016/j.ejps.2019.104990.
  • Wang Z. 2010. Effects of the process parameters on the initial burst release of poly(lactide- co -glycolide) microspheres containing bovine serum albumin by the double-emulsion solvent evaporation/extraction method. J of Applied Polymer Sci. 115(5):2599–2608. doi: 10.1002/app.30282.
  • Wu J-Z, Williams GR, Li HY, Wang DX, Li SD, Zhu LM. 2017. Insulin-loaded PLGA microspheres for glucose-responsive release. Drug Deliv. 24(1):1513–1525. doi: 10.1080/10717544.2017.1381200.
  • Yu J, Wang Q, Liu H, Shan X, Pang Z, Song P, Niu F, Hu L. 2020. Glucose-responsive microspheres as a smart drug delivery system for controlled release of insulin. Eur J Drug Metab Pharmacokinet. 45(1):113–121. doi: 10.1007/s13318-019-00588-2.
  • Zhai J, Ou Z, Zhong L, Wang YE, Cao LP, Guan S. 2020. Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics. Drug Deliv. 27(1):1667–1675. doi: 10.1080/10717544.2020.1850919.
  • Zhai J, Wang YE, Zhou X, Ma Y, Guan S. 2020. Long-term sustained release poly(lactic-co-glycolic acid) microspheres of asenapine maleate with improved bioavailability for chronic neuropsychiatric diseases. Drug Deliv. 27(1):1283–1291. doi: 10.1080/10717544.2020.1815896.
  • Zhou Z, Liu L, Liu Q, Yi Q, Zeng W, Zhao Y. 2012. Effect of surface modification of bioactive glass on properties of poly-L-lactide composite materials. J Macromolecul Sci Part B. 51(8):1637–1646. doi: 10.1080/00222348.2012.672295.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.